Northwestern Mutual Wealth Management’s Ovid Therapeutics OVID Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$207	Buy	+77	New	+$199	﹤0.01%	3946

Other funds holding OVID

Jupiter Topco New York $245B AUM

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Northwestern Mutual Wealth Management's OVID Position: Q2 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Ovid Therapeutics (OVID) in Q2 2026: 77 shares worth $207. The stake represents ﹤0.01% of the portfolio and ranks #3946 among its holdings.

131 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

Northwestern Mutual Wealth Management held 77 shares of Ovid Therapeutics worth $207 as of Q2 2026.
Ovid Therapeutics was a new Northwestern Mutual Wealth Management position in Q2 2026.
Ovid Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3946 holding.
131 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.